Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodolfo Sacco

Showing results (91-100 of 169) with videos related to

Pageof 17
Sort By:
Viruses|April 23, 2022
SARS-CoV-2 Gamma and Delta Variants of Concern Might Undermine Neutralizing Activity Generated in Response to BNT162b2 mRNA VaccinationLuigia Trabace, Lorenzo Pace, Maria Grazia Morgese, et al.
Cancers|November 2, 2019
Overview of Immune Checkpoint Inhibitors Therapy for Hepatocellular Carcinoma, and The ITA.LI.CA Cohort Derived Estimate of Amenability Rate to Immune Checkpoint Inhibitors in Clinical PracticeEdoardo G Giannini, Andrea Aglitti, Mauro Borzio, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 19, 2017
Management and prognosis of hepatocellular carcinoma in the elderly: Results of an in-field multicenter cohort studyMauro Borzio, Elena Dionigi, Alessandro Vitale, et al.
Journal of Clinical Medicine|August 6, 2020
Differential Diagnosis and Management of Diarrhea in Patients with Neuroendocrine TumorsSara Pusceddu, Roberta Elisa Rossi, Martina Torchio, et al.
Cancer|April 12, 2014
Determinants of alpha-fetoprotein levels in patients with hepatocellular carcinoma: implications for its clinical useEdoardo G Giannini, Giorgio Sammito, Fabio Farinati, et al.
Minerva Gastroenterology|March 9, 2022
Performance of a multicompounds nutraceutical formulation in patients with symptomatic uncomplicated diverticular diseaseGiovanni Brandimarte, Giovanni V Frajese, Stefano Bargiggia, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 27, 2016
Efficacy and safety of sofosbuvir/simeprevir plus flat dose ribavirin in genotype 1 elderly cirrhotic patients: A real-life studyAdriano M Pellicelli, Valeria Pace Palitti, Pascal Vignally, et al.
Cancers|April 30, 2021
Overview of Prognostic Systems for Hepatocellular Carcinoma and ITA.LI.CA External Validation of MESH and CNLC ClassificationsAlessandro Vitale, Fabio Farinati, Michele Finotti, et al.
The American Journal of Gastroenterology|January 6, 2016
Application of the Intermediate-Stage Subclassification to Patients With Untreated Hepatocellular CarcinomaEdoardo G Giannini, Alessandro Moscatelli, Gaia Pellegatta, et al.
The American Journal of Gastroenterology|June 19, 2018
Correction: Application of the Intermediate-Stage Subclassification to Patients With Untreated Hepatocellular CarcinomaEdoardo G Giannini, Alessandro Moscatelli, Gaia Pellegatta, et al.
Pageof 17

Showing results (91-100 of 169) with videos related to

Sort By:
Pageof 17
Viruses|April 23, 2022
SARS-CoV-2 Gamma and Delta Variants of Concern Might Undermine Neutralizing Activity Generated in Response to BNT162b2 mRNA VaccinationLuigia Trabace, Lorenzo Pace, Maria Grazia Morgese, et al.
Cancers|November 2, 2019
Overview of Immune Checkpoint Inhibitors Therapy for Hepatocellular Carcinoma, and The ITA.LI.CA Cohort Derived Estimate of Amenability Rate to Immune Checkpoint Inhibitors in Clinical PracticeEdoardo G Giannini, Andrea Aglitti, Mauro Borzio, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 19, 2017
Management and prognosis of hepatocellular carcinoma in the elderly: Results of an in-field multicenter cohort studyMauro Borzio, Elena Dionigi, Alessandro Vitale, et al.
Journal of Clinical Medicine|August 6, 2020
Differential Diagnosis and Management of Diarrhea in Patients with Neuroendocrine TumorsSara Pusceddu, Roberta Elisa Rossi, Martina Torchio, et al.
Cancer|April 12, 2014
Determinants of alpha-fetoprotein levels in patients with hepatocellular carcinoma: implications for its clinical useEdoardo G Giannini, Giorgio Sammito, Fabio Farinati, et al.
Minerva Gastroenterology|March 9, 2022
Performance of a multicompounds nutraceutical formulation in patients with symptomatic uncomplicated diverticular diseaseGiovanni Brandimarte, Giovanni V Frajese, Stefano Bargiggia, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 27, 2016
Efficacy and safety of sofosbuvir/simeprevir plus flat dose ribavirin in genotype 1 elderly cirrhotic patients: A real-life studyAdriano M Pellicelli, Valeria Pace Palitti, Pascal Vignally, et al.
Cancers|April 30, 2021
Overview of Prognostic Systems for Hepatocellular Carcinoma and ITA.LI.CA External Validation of MESH and CNLC ClassificationsAlessandro Vitale, Fabio Farinati, Michele Finotti, et al.
The American Journal of Gastroenterology|January 6, 2016
Application of the Intermediate-Stage Subclassification to Patients With Untreated Hepatocellular CarcinomaEdoardo G Giannini, Alessandro Moscatelli, Gaia Pellegatta, et al.
The American Journal of Gastroenterology|June 19, 2018
Correction: Application of the Intermediate-Stage Subclassification to Patients With Untreated Hepatocellular CarcinomaEdoardo G Giannini, Alessandro Moscatelli, Gaia Pellegatta, et al.
Pageof 17